Menu
Log in



  • Home
  • Paxlovid for the Treatment of COVID-19: Emergency Use Authorization Overview

Paxlovid for the Treatment of COVID-19: Emergency Use Authorization Overview

  • 08/17/2022
  • 2:00 PM - 3:00 PM (EDT)
  • Zoom Webinar

Registration is closed


This presentation is designed to provide information on the emergency use authorization of Paxlovid (nirmatrelvir; ritonavir oral tablets) for the treatment of COVID-19. The following topics will be discussed in detail during the live webinar.

Outline:

       SARS-CoV-2 Viral Replication Cycle: Proteolysis

       Nirmatrelvir: Mechanism of Action

       Co-administration of nirmatrelvir and ritonavir

       FDA Authorized Use

       Warnings

       Dosage and Administration

       Contraindications

       Drug Interactions

       Additional Information

Presented By:           

Rand Sulaiman, PharmD, BCIDP

Field Medical Director-Anti-Infectives (Indiana & Western Michigan)
Hospital Business Unit
Pfizer

INDIANA ACADEMY OF PHYSICIAN ASSISTANTS

Address: 140B Purcellville Gateway Drive, Suite 120, Purcellville, VA 20132

+1 (463) 388-3300, info@indianapas.org

© 2024 Indiana Association of PAs. All Rights Reserved.

Powered by Wild Apricot Membership Software